Table 1.

5-year incidence rates (2009–2013) for men and women by race

		Race
		White*		Black				AI/AN				API
	Total N	N	Rate	N	Rate	RR	95% CI	N	Rate	RR	95% CI	N	Rate	RR	95% CI
Men
Esophagus
Adenocarcinoma	4,639	4,372	5.7	121	1.4	0.2	(0.2, 0.3)	28	3.4	0.6	(0.4, 0.9)	118	1.0	0.2	(0.1, 0.2)
Squamous Cell	1,796	1,108	1.5	388	4.5	3.1	(2.7, 3.5)	15	2.0	1.4	(0.7, 2.3)	285	2.3	1.6	(1.4, 1.8)
Other	304	257	0.3	24	0.3	0.9	(0.6, 1.4)	~				21	0.2	0.5	(0.3, 0.8)
Kidney & Renal Pelvis
Kidney, NOS	19,406	4,816	6.6	901	10.5	1.6	(1.5, 1.7)	56	8.6	1.3	(1.0, 1.7)	708	6.1	0.9	(0.9, 1.0)
Renal Pelvis	1,082	937	1.3	44	0.6	0.5	(0.3, 0.6)	~				96	0.8	0.6	(0.5, 0.8)
Lung & Bronchus
Squamous	13,022	10,277	14.1	1547	20.6	1.5	(1.4, 1.5)	90	15.3	1.1	(0.9, 1.4)	1,108	9.7	0.7	(0.6, 0.7)
Small cell	6,173	5,095	6.7	549	6.8	1.0	(0.9, 1.1)	47	7.1	1.1	(0.8, 1.4)	482	4.1	0.6	(0.6, 0.7)
Adenocarcinoma	22,187	16,660	22.5	2644	31.4	1.4	(1.3, 1.5)	99	14.9	0.7	(0.5, 0.8)	2,784	23.2	1.0	(1.0, 1.1)
Large cell	926	704	0.9	143	1.7	1.8	(1.5, 2.2)	~				78	0.6	0.7	(0.5, 0.9)
Malignant neoplasm &   Carcinoma unspecified	6,481	4,816	6.6	901	10.5	1.6	(1.5, 1.7)	56	8.6	1.3	(1.0, 1.7)	708	6.1	0.9	(0.9, 1.0)
Thyroid
Papillary	6,137	5,100	6.5	262	2.7	0.4	(0.4, 0.5)	38	4.1	0.6	(0.4, 0.9)	737	5.4	0.8	(0.8, 0.9)
Follicular	558	433	0.6	52	0.6	1.0	(0.7, 1.4)	~				69	0.5	1.0	(0.7, 1.3)
Medullary	176	148	0.2	13	0.1	0.7	(0.4, 1.3)	~				14	0.1	0.6	(0.3, 1.0)
Anaplastic	98	74	0.1	8	0.1	0.9	(0.4, 2.0)	~				16	0.1	1.5	(0.8, 2.6)
Women
Breast
HR+/HER2+	10,968	8,159	9.6	1257	10.1	1.1	(1.0, 1.1)	101	9.7	1.0	(0.8, 1.2)	1451	9.0	0.9	(0.9, 1.0)
HR−/HER2+	4,832	3,386	3.9	602	4.9	1.2	(1.1, 1.4)	37	3.7	0.9	(0.7, 1.3)	807	4.9	1.2	(1.1, 1.3)
HR+/HER2−	80,317	63608	72.4	7075	59.4	0.8	(0.8, 0.8)	491	51.8	0.7	(0.7, 0.8)	9143	56.8	0.8	(0.8, 0.8)
Triple negative	12,143	8,555	10.0	2330	18.9	1.9	(1.8, 2.0)	67	7.1	0.7	(0.5, 0.9)	1191	7.4	0.7	(0.7, 0.8)
Esophagus
Adenocarcinoma	784	717	0.8	37	0.3	0.4	(0.3, 0.6)	~				22	0.1	0.2	(0.1, 0.3)
Squamous Cell	1,057	726	0.8	212	1.8	2.2	(1.9, 2.6)	~				114	0.7	0.9	(0.7, 1.1)
Other	110	89	0.1	15	0.1	1.5	(0.8, 2.6)	~				~
Kidney & Renal Pelvis
Kidney, NOS	10,807	8,450	9.6	1,376	11.6	1.2	(1.1, 1.3)	155	16.0	1.7	(1.4, 2.0)	826	5.2	0.5	(0.5, 0.6)
Renal Pelvis	815	663	0.7	58	0.6	0.8	(0.6, 1.0)	~				91	0.6	0.8	(0.6, 1.0)
Lung
Squamous	7,905	6,495	7.4	924	8.5	1.2	(1.1, 1.2)	65	8.0	1.1	(0.8, 1.4)	421	2.7	0.4	(0.3, 0.4)
Small cell	6,068	5,185	5.8	566	5.0	0.9	(0.8, 0.9)	47	5.1	0.9	(0.6, 1.2)	270	1.7	0.3	(0.3, 0.3)
Adenocarcinoma	24,720	18,911	21.1	2,758	23.7	1.1	(1.1, 1.2)	86	9.9	0.5	(0.4, 0.6)	2,965	18.9	0.9	(0.9, 0.9)
Large cell	747	585	0.7	106	0.9	1.4	(1.1, 1.7)	~				51	0.3	0.5	(0.4, 0.7)
Malignant neoplasm &   Carcinoma unspecified	5,110	3,971	4.4	697	6.0	1.4	(1.3, 1.5)	31	4.0	0.9	(0.6, 1.3)	411	2.7	0.6	(0.5, 0.7)
Thyroid
Papillary	20,401	15,973	20.2	1,378	11.0	0.5	(0.5, 0.6)	152	15.2	0.8	(0.6, 0.9)	2,898	18.2	0.9	(0.9, 0.9)
Follicular	1,381	1,025	1.3	179	1.5	1.2	(1.0, 1.4)	14	1.5	1.2	(0.6, 2.1)	163	1.0	0.8	(0.7, 1.0)
Medullary	290	237	0.3	33	0.3	0.9	(0.6, 1.3)	~				19	0.1	0.4	(0.3, 0.7)
Anaplastic	167	133	0.1	11	0.1	0.7	(0.3, 1.3)	~				23	0.2	1.1	(0.6, 1.7)

^*Reference group

^~Counts of 10 or less were suppressed